Arcutis Biotherapeutics, Inc. ARQT EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s EV / sales?
- Arcutis Biotherapeutics, Inc. (ARQT) reported EV / sales of 7.2× in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s EV / sales changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s EV / sales decreased by 19.6% year-over-year, from 9× to 7.2×.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s EV / sales?
- Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s EV / sales has grown at a -67.6% compound annual growth rate (CAGR), from 284.7× to 9.6×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.